Quick Takeaways
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR).
- Disclosed ownership: 9.1%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"Soleus Capital Master Fund, L.P. disclosed 9.1% ownership in NOVOCURE LIMITED Ordinary Shares, no par value per share (NVCR) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Managing Member of the Managing Member of the General Partner of Soleus Capital Master Fund, L.P. | |
| Soleus Capital, LLC | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Managing Member of the Managing Member of Soleus Capital, LLC | |
| Soleus Capital Group, LLC | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Managing Member | |
| Soleus Capital Management, L.P. | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Managing Member of the General Partner of Soleus Capital Management, L.P. | |
| Soleus GP, LLC | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Managing Member | |
| Guy Levy | 9.1% | 10,492,391 | 0 | 10,492,391 | /s/ Guy Levy | Guy Levy / Individual |